Clinical Progress of Fruquintinib in Colorectal Cancer: An Overview

Colorectal cancer (CRC) is one of the most common malignancies worldwide, with high morbidity and mortality rates. Conventional treatments, including surgery, radiotherapy, and chemotherapy, have limited effects on advanced and metastatic CRC (mCRC). Fruquintinib, a novel and highly selective vascul...

Full description

Saved in:
Bibliographic Details
Main Authors: Yejie Xie, Shu Tang, Ziheng Qin, Chaogang Yang
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/18/2/280
Tags: Add Tag
No Tags, Be the first to tag this record!